Cannabis Market: Size, Revenue, Trends, Research Report
Cannabis Market

Cannabis Market: Size, Revenue, Trends, Research Report

The Cannabis Market is estimated at USD 27.7 billion in 2022 and is projected to reach USD 82.3 billion by 2027, at a CAGR of 24.3%.

The cannabis industry refers to the collection of businesses and enterprises involved in the cultivation, processing, distribution, and sale of cannabis and cannabis-related products. This industry encompasses a wide range of activities, from growing cannabis plants to producing medicinal or recreational cannabis products such as oils, edibles, and topical creams. The global cannabis market size is estimated to be valued at USD 27.7 billion in 2022 and is projected to reach USD 82.3 billion by 2027, recording a CAGR of 24.3% in terms of value.

In recent years, the cannabis industry has experienced significant growth and expansion, driven by increasing legalization efforts in various parts of the world, shifting public attitudes towards cannabis use, and recognition of its potential medicinal benefits. This growth has led to the emergence of a diverse range of companies, including large-scale producers, dispensaries, manufacturers of cannabis-derived pharmaceuticals, technology firms developing innovative cultivation and extraction methods, and ancillary businesses providing services such as packaging, branding, and legal support.

Download PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=201768301

Cannabis Market Forecast

  • Global Growth: The global cannabis market is expected to see substantial growth, driven by increasing legalization for both medical and recreational use in various regions. Markets such as North America, Europe, and parts of Asia-Pacific are anticipated to contribute significantly to this growth.

  • Legalization Efforts: Continued efforts towards cannabis legalization in more countries and states are likely to fuel market expansion. As regulations evolve, barriers to entry may decrease, allowing more companies to enter the market and diversify offerings.

  • Medical Cannabis: The medical cannabis segment is expected to continue growing, driven by increasing recognition of cannabis's therapeutic properties and its potential to treat various medical conditions. Pharmaceutical companies are also investing in cannabis-based medications, contributing to market expansion.

  • Recreational Cannabis: The recreational cannabis market is forecasted to see continued growth, particularly in regions where legalization has occurred or is expected. Changing attitudes towards cannabis use and increasing consumer acceptance are key drivers in this segment.

  • Product Innovation: Innovation in cannabis products, including new delivery methods, formulations, and product categories, is expected to drive market growth. This includes developments in edibles, beverages, topicals, and concentrates, catering to diverse consumer preferences.

  • Investment and M&A Activity: The cannabis industry is likely to see continued investment and merger and acquisition (M&A) activity as companies seek to expand market share, enter new regions, and diversify product portfolios. Consolidation within the industry may also occur as companies strive for efficiency and scale.

  • Regulatory Landscape: Regulatory changes and government policies will continue to play a significant role in shaping the cannabis market. Continued legalization efforts, changes in taxation, and evolving regulations regarding cultivation, distribution, and sales will impact market dynamics.

  • Market Challenges: Despite growth opportunities, the cannabis industry faces challenges such as regulatory uncertainty, banking limitations, supply chain issues, and competition from the illicit market. Overcoming these challenges will be crucial for sustained market expansion.

Cannabis Market Share

  • Canopy Growth Corporation (Canada)

  • Aurora Cannabis Inc. (Canada)

  • VIVO Cannabis Inc. (Canada)

  • Tilary Inc. (US)

  • Unrivaled Brand Inc. (US)

  • HEXO Corp. (Canada)

  • Medical Marijuana Inc. (US)

  • The Cronos Group (Canada)

  • Medmen Enterprise Inc. (US)

  • Cresco Labs (US)

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=201768301

The demand for medical cannabis in South America is driven by the increased legalization of medical cannabis within various countries

The market in the region is driven by the legalization of medical cannabis. The legalization of cannabis originated from Uruguay and Colombia, which was later joined by Argentina, Brazil, Chile, and other South American countries. Although personal cultivation of recreational cannabis for personal consumption is legal in many countries in the region, the commercial sale is limited only to Uruguay. Several countries in South America have decriminalized possession of small amounts for personal use such as Chile, Colombia, Costa, Ecuador, and Peru. The South American cannabis market is also growing tremendously as many local companies are receiving EU-Good Manufacturing (GMP) certification, and countries are approving favorable legislation. This market also benefits from the favorable climate, low-cost labor, and construction costs, as they are very low as compared to North America.

To view or add a comment, sign in

Insights from the community

Others also viewed

Explore topics